Wells Fargo Maintains Overweight on Johnson & Johnson, Raises Price Target to $165

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $155 to $165.

Benzinga · 01/09/2020 13:39

Wells Fargo analyst Larry Biegelsen maintains Johnson & Johnson (NYSE:JNJ) with a Overweight and raises the price target from $155 to $165.